Sacubitril and Valsartan

Product NDC
82293-029
11-digit product format
822930029
Labeler code
82293
Product ID
82293-029_4d34c331-a1f9-937a-e063-6294a90a66b7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Sacubitril and Valsartan
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Novugen Pharma (USA) LLC
Application
ANDA213611
Marketing category
ANDA
Marketing start
2025-07-16
Substance
SACUBITRIL; VALSARTAN
Active strength
97; 103 mg/1; mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Neprilysin Inhibitor [EPC], Neprilysin Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A213611-001SACUBITRIL AND VALSARTANSACUBITRIL; VALSARTAN24MG;26MGTABLET / ORALAB2025-07-16
A213611-002SACUBITRIL AND VALSARTANSACUBITRIL; VALSARTAN49MG;51MGTABLET / ORALAB2025-07-16
A213611-003SACUBITRIL AND VALSARTANSACUBITRIL; VALSARTAN97MG;103MGTABLET / ORALAB2025-07-16

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A213611-001AB
A213611-002AB
A213611-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A213611-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2025-07-16caaa826d4ba7…
2026-08-18 06:07:402026-07A213611-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2025-07-16caaa826d4ba7…
2026-08-18 06:07:402026-07A213611-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2025-07-16caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A213611-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2025-07-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213611-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2025-07-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213611-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2025-07-16011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213611-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2025-07-1631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213611-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2025-07-1631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213611-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2025-07-1631067a03dcf5…
2025-08-23 18:47 UTC2025-08A213611-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2025-07-166a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213611-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2025-07-166a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213611-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2025-07-166a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213611-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2025-07-16a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213611-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2025-07-16a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213611-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2025-07-16a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A213611-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A213611-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A213611-003AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A213611-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213611-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213611-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213611-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213611-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213611-003AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A213611-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213611-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213611-003AB16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213611-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213611-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213611-003AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Sacubitril and Valsartan
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SACUBITRIL97 mg/1
VALSARTAN103 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
80M03YXJ7IInternal UNII lookup
17ERJ0MKGIInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1656340Internal RxNorm lookup
1656349Internal RxNorm lookup
1656354Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
747eeb5c-ac2f-474f-b6d2-0586d12653a6Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
692a3434-fece-49c6-9b7d-ed7aefc52b50Product name320260317
b15e9aa6-d523-ca97-480e-570e0543a342Product name420251024
265792b3-b999-c010-7364-a7db20b9d4d9Product name520250515
e7dfdaab-7cf9-4f89-804c-eff5108d94d1Product name920250305
b6abae2f-ee27-47bc-b150-54dc8d969483Product name220250221
52311e76-a520-4bd2-9d5b-e0b6d6f44519Product name220231208
a8e65197-7914-7acf-c7ec-914d53819b34Product name320190624
f5231d08-c52b-a5a0-ba93-675895c292beProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82293-029-10Sacubitril and Valsartan60 in 1 BOTTLETABLET, FILM COATED602
82293-029-20Sacubitril and Valsartan180 in 1 BOTTLETABLET, FILM COATED1802
82293-029-30Sacubitril and Valsartan100 in 1 BOX, UNIT-DOSETABLET, FILM COATED1002
82293-029-31Sacubitril and Valsartan10 in 1 BLISTER PACKTABLET, FILM COATED102

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
82293-029-10EA - Each82293-0297d2a59bd-ea97-4839-b89e-796942dcedd612025-09-12
82293-029-20EA - Each82293-029fe99e50d-15dc-4728-a14d-cb2d8841cc3412025-09-12

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sacubitril and ValsartanSACUBITRIL AND VALSARTANAmerican Health Packagingd85015d5-f619-4a58-b6ab-5e39af3f79d82026-06-11Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 213611
application number: ANDA213611
Sacubitril and ValsartanSACUBITRIL AND VALSARTANNovugen Pharma (USA) LLC747eeb5c-ac2f-474f-b6d2-0586d12653a62026-03-17Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 213611
application number: ANDA213611
ndc (product): 82293-029
Sacubitril and ValsartanSACUBITRIL AND VALSARTANNovugen Pharma (USA) LLCec37696b-eaac-4c74-9328-94857ce998e52025-07-17Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 213611
application number: ANDA213611

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1656340sacubitril 24 MG / valsartan 26 MG Oral TabletPSN747eeb5c-ac2f-474f-b6d2-0586d12653a62
1656349sacubitril 49 MG / valsartan 51 MG Oral TabletPSN747eeb5c-ac2f-474f-b6d2-0586d12653a62
1656354sacubitril 97 MG / valsartan 103 MG Oral TabletPSN747eeb5c-ac2f-474f-b6d2-0586d12653a62
1656340sacubitril 24 MG / valsartan 26 MG Oral TabletSCD747eeb5c-ac2f-474f-b6d2-0586d12653a62
1656349sacubitril 49 MG / valsartan 51 MG Oral TabletSCD747eeb5c-ac2f-474f-b6d2-0586d12653a62
1656354sacubitril 97 MG / valsartan 103 MG Oral TabletSCD747eeb5c-ac2f-474f-b6d2-0586d12653a62
1656340sacubitril 24 MG / valsartan 26 MG Oral TabletPSNd85015d5-f619-4a58-b6ab-5e39af3f79d81
1656349sacubitril 49 MG / valsartan 51 MG Oral TabletPSNd85015d5-f619-4a58-b6ab-5e39af3f79d81
1656354sacubitril 97 MG / valsartan 103 MG Oral TabletPSNd85015d5-f619-4a58-b6ab-5e39af3f79d81
1656340sacubitril 24 MG / valsartan 26 MG Oral TabletSCDd85015d5-f619-4a58-b6ab-5e39af3f79d81
1656349sacubitril 49 MG / valsartan 51 MG Oral TabletSCDd85015d5-f619-4a58-b6ab-5e39af3f79d81
1656354sacubitril 97 MG / valsartan 103 MG Oral TabletSCDd85015d5-f619-4a58-b6ab-5e39af3f79d81

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
82293-029-108229300291060 TABLET, FILM COATED in 1 BOTTLE (82293-029-10) 2025-07-16NoNoCurrent
82293-029-2082293002920180 TABLET, FILM COATED in 1 BOTTLE (82293-029-20) 2025-07-16NoNoCurrent
82293-029-3082293002930100 BLISTER PACK in 1 BOX, UNIT-DOSE (82293-029-30) / 10 TABLET, FILM COATED in 1 BLISTER PACK (82293-029-31) 100 blister pack2025-07-16NoNoCurrent
82293-029-318229300293110 in 1 BLISTER PACKHistorical